ATE315085T1 - Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren. - Google Patents

Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren.

Info

Publication number
ATE315085T1
ATE315085T1 AT99920236T AT99920236T ATE315085T1 AT E315085 T1 ATE315085 T1 AT E315085T1 AT 99920236 T AT99920236 T AT 99920236T AT 99920236 T AT99920236 T AT 99920236T AT E315085 T1 ATE315085 T1 AT E315085T1
Authority
AT
Austria
Prior art keywords
apolipoprotein
expression
transgenic mice
testing methods
transgenic animal
Prior art date
Application number
AT99920236T
Other languages
English (en)
Inventor
Lennart Mucke
Jacob Raber
Manuel Buttini
Robert W Mahley
Robert E Pitas
Original Assignee
David Gladstone Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Gladstone Inst filed Critical David Gladstone Inst
Application granted granted Critical
Publication of ATE315085T1 publication Critical patent/ATE315085T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT99920236T 1998-04-30 1999-04-29 Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren. ATE315085T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/070,670 US6046381A (en) 1998-04-30 1998-04-30 Apolipoprotein E transgenic mice and assay methods

Publications (1)

Publication Number Publication Date
ATE315085T1 true ATE315085T1 (de) 2006-02-15

Family

ID=22096690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920236T ATE315085T1 (de) 1998-04-30 1999-04-29 Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren.

Country Status (8)

Country Link
US (1) US6046381A (de)
EP (1) EP1005542B1 (de)
JP (1) JP2002507898A (de)
AT (1) ATE315085T1 (de)
AU (1) AU747691B2 (de)
CA (1) CA2290707C (de)
DE (1) DE69929324T2 (de)
WO (1) WO1999055852A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964598B2 (en) * 1995-10-17 2011-06-21 The J. David Gladstone Institutes ApoE4 domain interaction inhibitors and methods of use thereof
US7129061B1 (en) * 1996-08-07 2006-10-31 Biogen Idec Ma Inc. Tumor necrosis factor related ligand
SK10042001A3 (sk) 1999-01-15 2001-12-03 Biogen, Inc. Farmaceutická kompozícia obsahujúca činidlo blokujúce proteín tweak alebo receptor tweak
AU762931B2 (en) * 1999-03-16 2003-07-10 Serex, Inc. Method and device for detection of Apo A, Apo B and the ratio thereof in saliva
US6982361B1 (en) * 2000-02-25 2006-01-03 The Regents Of The University Of California Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal
AU2001284843A1 (en) * 2000-08-14 2002-02-25 Iogenetics, Llc Fatty liver disease resistant bovines
AU2001294654A1 (en) * 2000-09-25 2002-04-08 The Regents Of The University Of California Model for neurodegenerative diseases involving amyloid accumulation
AU2002214644A1 (en) * 2000-10-13 2002-04-22 University Of Cincinnati Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype
AU2002211678A1 (en) * 2000-10-13 2002-04-22 University Of Cincinnati Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype
ATE398177T1 (de) * 2000-11-03 2008-07-15 David Gladstone Inst Verfahren zur behandlung von erkrankungen im zusammenhang mit apoe
US7081561B2 (en) * 2001-03-16 2006-07-25 The Regents Of The University Of California Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
JP2003055266A (ja) * 2001-06-04 2003-02-26 Univ Texas Syst Ｍｅｋ５ならびに心臓肥大および拡張型心筋症に関連する方法および組成物
US20040092013A1 (en) * 2001-08-14 2004-05-13 Snyder Evan Y. Method of treating alzheimer's disease with cell therapy
EP1494713A4 (de) * 2002-04-09 2005-12-28 Biogen Idec Inc Verfahren zur behandlung von zuständen im zusammenhang mit tweak
EP1535512A4 (de) * 2002-07-15 2007-12-19 Takeda Pharmaceutical KRANKHEITSMODELLTIER MIT IN DIESES BERTRAGENEM HETEROLOGEN PPARa-GEN UND SEINE VERWENDUNG
US7432355B2 (en) 2002-08-09 2008-10-07 The J. David Gladstone Institutes Apolipoprotein E stable folding intermediate and methods of use thereof
US7297836B2 (en) 2003-03-24 2007-11-20 The J. David Gladstone Institutes Methods of detecting neurological disorders
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US7612179B2 (en) 2003-11-28 2009-11-03 Astrazeneca Ab antibodies binding to a C-terminal fragment of apoliopoprotein E
KR20120108061A (ko) 2003-11-28 2012-10-04 다이엑스 코포레이션 아포지단백질 ｅ의 ｃ­말단 단편에 결합하는 항체
US7579224B2 (en) * 2005-01-21 2009-08-25 Semiconductor Energy Laboratory Co., Ltd. Method for manufacturing a thin film semiconductor device
US20090124993A1 (en) 2005-02-17 2009-05-14 Burkly Linda C Treating neurological disorders
EP1885388B1 (de) 2005-05-10 2013-09-11 Biogen Idec MA Inc. Behandlung und beurteilung von entzündlichen erkrankungen
WO2006138219A2 (en) 2005-06-13 2006-12-28 Biogen Idec Ma Inc. Methods of diagnosis / prognosis of inflammatory conditions
US20090082271A1 (en) * 2005-12-07 2009-03-26 Mahley Robert W Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof
US8512958B2 (en) * 2005-12-07 2013-08-20 The J. David Gladstone Institutes Methods of identifying agents that modulate mitochondrial function
US20090136456A1 (en) * 2006-12-22 2009-05-28 Yadong Huang Methods of treating neurodegenerative disorders
EP2496189A4 (de) 2009-11-04 2016-05-11 Nitinol Devices And Components Inc Entwurf für einen stent mit alternierender ringförmiger brücke und verwendungsverfahren dafür
EP2624791B1 (de) 2010-10-08 2017-06-21 Confluent Medical Technologies, Inc. Stent mit alternierender ringförmiger brücke
EP3599842B1 (de) * 2017-03-21 2024-08-07 The Jackson Laboratory Genetisch veränderte maus, die humanes apoe4 und maus-trem2.p.r47h ausdrückt, und verfahren zur verwendung davon
EP3914071A4 (de) * 2019-01-23 2022-10-19 The Regents of the University of California Menschliche genomische konstruierte reporterzellen und mausmodelle zum screening von therapeutika gegen mit mikroglia-expression erkrankung assoziierte gene
CN110684765A (zh) * 2019-09-20 2020-01-14 浙江大学 痴呆相关致病基因捕获探针的筛选方法、捕获基因组和产品及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
WO1994013798A1 (en) * 1992-12-16 1994-06-23 Bergmann Johanna E Agents for the prevention and treatment of human alzheimer's disease
WO1995006470A1 (en) * 1993-08-30 1995-03-09 Merck & Co., Inc. Prevention and treatment of alzheimer's disease
CA2170727A1 (en) * 1993-08-31 1995-03-09 Warren J. Strittmatter Methods and compositions for binding tau and map2c proteins
WO1996040895A1 (en) * 1995-06-07 1996-12-19 Athena Neurosciences, Inc. Method for identifying alzheimer's disease therapeutics using transgenic animal models
US5767337A (en) * 1995-07-31 1998-06-16 Duke University Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice

Also Published As

Publication number Publication date
JP2002507898A (ja) 2002-03-12
AU747691B2 (en) 2002-05-16
EP1005542A4 (de) 2003-05-14
EP1005542B1 (de) 2006-01-04
DE69929324D1 (de) 2006-03-30
AU3778199A (en) 1999-11-16
CA2290707C (en) 2007-02-13
WO1999055852A1 (en) 1999-11-04
EP1005542A1 (de) 2000-06-07
DE69929324T2 (de) 2006-09-28
US6046381A (en) 2000-04-04
CA2290707A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
ATE315085T1 (de) Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren.
Meredith et al. Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel
Meng et al. Setting clock speed in mammals: the CK1ɛ tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins
Guy et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Mayer et al. Female reproductive maturation in the absence of kisspeptin/GPR54 signaling
Voigt et al. Genetic labeling of Tas1r1 and Tas2r131 taste receptor cells in mice
Tong et al. Oncomodulin, an EF-hand Ca2+ buffer, is critical for maintaining cochlear function in mice
HK1013841A1 (en) Transgenic non-human animals lacking prion proteins.
Fang et al. Outer hair cell‐specific prestin‐CreERT2 knockin mouse lines
Adams et al. Renin enhancer is critical for control of renin gene expression and cardiovascular function
Zhang et al. Generation of Evc2/Limbin global and conditional KO mice and its roles during mineralized tissue formation
Azkona et al. Characterization of a mouse model overexpressing beta‐site APP‐cleaving enzyme 2 reveals a new role for BACE2
Tharmarajah et al. Melanocyte development in the mouse tail epidermis requires the Adamts9 metalloproteinase
Cleverley et al. A novel knockout mouse for the small EDRK-rich factor 2 (Serf2) showing developmental and other deficits
Lindley et al. Generation of mice with a conditional Lbh null allele
Zhou et al. Murine peripherin gene sequences direct Cre recombinase expression to peripheral neurons in transgenic mice
Tian et al. Creation of a transgenic mouse for hair‐cell gene targeting by using a modified bacterial artificial chromosome containing Prestin
Ankamreddy et al. Foxi3 GFP and Foxi3 CreER mice allow identification and lineage labeling of pharyngeal arch ectoderm and endoderm, and tooth and hair placodes
Eriksson et al. Functional expression of Cre recombinase in sub‐regions of mouse CNS and retina
DE69738668D1 (de) Transgentier-modell für die krankheit von alzheimer
WO1999037756A8 (en) Non-human animal having a functionally disrupted slp-76 gene
WO2004063354A3 (en) Compositions and methods for characterizing and regulating wnt pathways
Quinn et al. A site-specific, single-copy transgenesis strategy to identify 5′ regulatory sequences of the mouse testis-determining gene Sry
EP1420637A4 (de) Transgene nager als tiermodelle für die modulation des b1-bradykininrezeptorproteins
Koo et al. Identification of an enhancer region in the mouse ephA8 locus directing expression to the anterior region of the dorsal mesencephalon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties